Terms: = Breast cancer AND CASP8, ALPS2B, 841, ENSG00000064012, MGC78473, CAP4, MACH, MCH5, FLICE AND Treatment
131 results:
1. Noscapine and Apoptosis in breast and Other cancers.
Calaf GM; Crispin LA; Quisbert-Valenzuela EO
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542508
[TBL] [Abstract] [Full Text] [Related]
2. Exploring the apoptotic effects of sericin on HCT116 cells through comprehensive nanostring transcriptomics and proteomics analysis.
Ratanabunyong S; Siriwaseree J; Wanaragthai P; Krobthong S; Yingchutrakul Y; Kuaprasert B; Choowongkomon K; Aramwit P
Sci Rep; 2024 Jan; 14(1):2366. PubMed ID: 38287097
[TBL] [Abstract] [Full Text] [Related]
3. Yttrium Oxide nanoparticles induce cytotoxicity, genotoxicity, apoptosis, and ferroptosis in the human triple-negative breast cancer MDA-MB-231 cells.
Emad B; WalyEldeen AA; Hassan H; Sharaky M; Abdelhamid IA; Ibrahim SA; Mohamed HR
BMC Cancer; 2023 Nov; 23(1):1151. PubMed ID: 38012585
[TBL] [Abstract] [Full Text] [Related]
4. High inter-laboratory variability in the assessment of HER2-low breast cancer: a national registry study on 50,714 Danish patients.
Nielsen K; Sode M; Jensen MB; Berg T; Knoop A; Ejlertsen B; Lænkholm AV
Breast Cancer Res; 2023 Nov; 25(1):139. PubMed ID: 37946261
[TBL] [Abstract] [Full Text] [Related]
5. Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14 324 women in 16 trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Lancet; 2023 Nov; 402(10416):1991-2003. PubMed ID: 37931633
[TBL] [Abstract] [Full Text] [Related]
6. Clinicopathological characteristics, evolution, treatment pattern and outcomes of hormone-receptor-positive/HER2-low metastatic breast cancer.
You S; Gong C; Li Y; Xie Y; Li Y; Zhao Y; Wang B
Front Endocrinol (Lausanne); 2023; 14():1270453. PubMed ID: 37881502
[TBL] [Abstract] [Full Text] [Related]
7. Thymus Vulgaris Oil Nanoemulsion: Synthesis, Characterization, Antimicrobial and Anticancer Activities.
Doghish AS; Shehabeldine AM; El-Mahdy HA; Hassanin MMH; Al-Askar AA; Marey SA; AbdElgawad H; Hashem AH
Molecules; 2023 Oct; 28(19):. PubMed ID: 37836753
[TBL] [Abstract] [Full Text] [Related]
8. Insights adjusting for non-adherence in randomized clinical trials: a reanalysis of an adjuvant trial of tamoxifen duration in early breast cancer.
Giudici F; Pistilli B; Vaz-Luis I; Karimi M; Delaloge S; Bachelot T; Michiels S; Bardet A
Br J Cancer; 2023 Oct; 129(9):1516-1523. PubMed ID: 37697030
[TBL] [Abstract] [Full Text] [Related]
9. Doxorubicin-loaded Niosomes functionalized with gelatine and alginate as pH-responsive drug delivery system: A 3D printing approach.
Zaer M; Moeinzadeh A; Abolhassani H; Rostami N; Tavakkoli Yaraki M; Seyedi SA; Nabipoorashrafi SA; Bashiri Z; Moeinabadi-Bidgoli K; Moradbeygi F; Farmani AR; Hossein-Khannazer N
Int J Biol Macromol; 2023 Dec; 253(Pt 2):126808. PubMed ID: 37689301
[TBL] [Abstract] [Full Text] [Related]
10. Does Boric Acid Inhibit Cell Proliferation on MCF-7 and MDA-MB-231 Cells in Monolayer and Spheroid Cultures by Using Apoptosis Pathways?
Bayram D; Özgöçmen M; Çelik DA; Sarman E; Sevimli M
Biol Trace Elem Res; 2024 May; 202(5):2008-2021. PubMed ID: 37572183
[TBL] [Abstract] [Full Text] [Related]
11. A National Health and Wellness SMS Text Message Program for breast cancer Survivors During COVID-19 (EMPOWER-SMS COVID-19): Mixed Methods Evaluation Using the RE-AIM Framework.
Singleton AC; Raeside R; Hyun KK; Hayes M; Sherman KA; Elder E; Redfern J; Partridge SR
J Med Internet Res; 2023 Jul; 25():e45164. PubMed ID: 37490319
[TBL] [Abstract] [Full Text] [Related]
12. Recent advancement of HDAC inhibitors against breast cancer.
Mehmood SA; Sahu KK; Sengupta S; Partap S; Karpoormath R; Kumar B; Kumar D
Med Oncol; 2023 Jun; 40(7):201. PubMed ID: 37294406
[TBL] [Abstract] [Full Text] [Related]
13. Effect of Smilax spp. and Phellinus linteus combination on cytotoxicity and cell proliferation of breast cancer cells.
Chalertpet K; Sangkheereeput T; Somjit P; Bankeeree W; Yanatatsaneejit P
BMC Complement Med Ther; 2023 Jun; 23(1):177. PubMed ID: 37264344
[TBL] [Abstract] [Full Text] [Related]
14. Mutational signatures for breast cancer diagnosis using artificial intelligence.
Odhiambo P; Okello H; Wakaanya A; Wekesa C; Okoth P
J Egypt Natl Canc Inst; 2023 May; 35(1):14. PubMed ID: 37184779
[TBL] [Abstract] [Full Text] [Related]
15. 3D-printing-assisted synthesis of paclitaxel-loaded niosomes functionalized by cross-linked gelatin/alginate composite: Large-scale synthesis and in-vitro anti-cancer evaluation.
Hosseini F; Mirzaei Chegeni M; Bidaki A; Zaer M; Abolhassani H; Seyedi SA; Nabipoorashrafi SA; Ashrafnia Menarbazari A; Moeinzadeh A; Farmani AR; Tavakkoli Yaraki M
Int J Biol Macromol; 2023 Jul; 242(Pt 1):124697. PubMed ID: 37156313
[TBL] [Abstract] [Full Text] [Related]
16. PARP Inhibitors for the treatment of BRCA1/2-Mutated Metastatic breast cancer: A Systematic Review and Meta-analysis.
Kunwor R; Silver DP; Abu-Khalaf M
Hematol Oncol Stem Cell Ther; 2023 Apr; 16(3):186-196. PubMed ID: 37023220
[TBL] [Abstract] [Full Text] [Related]
17. Evaluation of HER-2 positive breast cancer treated with dual-targeted treatment of trastuzumab plus pertuzumab.
Jiang S; Geng S; Gao X; Liu T; Luo X; Wang N; Shi N; Dong M
Immunopharmacol Immunotoxicol; 2023 Oct; 45(5):616-625. PubMed ID: 36809922
[No Abstract] [Full Text] [Related]
18. Cellular senescence in the response of HR
Klapp V; Buqué A; Bloy N; Sato A; Yamazaki T; Zhou XK; Formenti SC; Galluzzi L; Petroni G
J Transl Med; 2023 Feb; 21(1):110. PubMed ID: 36765430
[TBL] [Abstract] [Full Text] [Related]
19. breast cancer risk among thyroid cancer survivors and the role of I-131 treatment.
Tran TV; Rubino C; Allodji R; Andruccioli M; Bardet S; Diallo I; Dottorini M; Garsi J; Hall P; Henry-Amar M; Lamart S; Le Thai F; Lönn S; Ricard M; Schvartz C; Schlumberger M; Journy N; de Vathaire F
Br J Cancer; 2022 Dec; 127(12):2118-2124. PubMed ID: 36224404
[TBL] [Abstract] [Full Text] [Related]
20. Androgen and oestrogen receptor co-expression determines the efficacy of hormone receptor-mediated radiosensitisation in breast cancer.
Michmerhuizen AR; Lerner LM; Ward C; Pesch AM; Zhang A; Schwartz R; Wilder-Romans K; Eisner JR; Rae JM; Pierce LJ; Speers CW
Br J Cancer; 2022 Sep; 127(5):927-936. PubMed ID: 35618789
[TBL] [Abstract] [Full Text] [Related]
[Next]
